The Medicine Maker | Regulation & Standards

Filter by

Bioprocessing Interviews Regulation & Standards Standards & Regulation Quality & Compliance Technology & Manufacturing Sponsored

Moving Beyond Document-Based Validation

July 2, 2026

How UCB is improving traceability, audit readiness, and visibility.

1 min read

Cell & Gene Development & Clinical Regulation & Standards

Why Early QC Planning Matters in Cell and Gene Therapy

By Laurent Claisse

June 30, 2026

Late-stage CMC setbacks often begin with early QC decisions that shape cell and gene therapy timelines, costs, and regulatory outcomes

7 min read

Why Early QC Planning Matters in Cell and Gene Therapy

Small Molecules Drug Discovery Formulation Regulation & Standards

Reformulating the Future of Small Molecules

June 30, 2026

A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines

1 min read

Reformulating the Future of Small Molecules

Bioprocessing Interviews Technology & Manufacturing Digital Technologies Quality & Compliance Regulation & Standards Sponsored

How Zealand Pharma Is Scaling Quality Without Complexity

June 29, 2026

How connected quality systems can help growing biotechs remain agile.

0 min read

How Zealand Pharma Is Scaling Quality Without Complexity

Cell & Gene Development & Clinical Outsourcing Regulation & Standards Business & Trends Technology & Manufacturing

Roving Reporter Asks: What Are Recent Breakthroughs Telling Us About the CGT Field’s Maturity?

June 25, 2026

IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore what recent clinical, regulatory, and commercial milestones reveal about the next phase of cell and gene therapy